Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Surgeons try High-Tech goggles to spot hidden tumors during keyhole surgery

NCT ID NCT06067971

Knowledge-focused Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study tested whether augmented reality (AR) can help surgeons during laparoscopic surgery for uterine fibroids or adenomyosis. AR overlays images from pre-surgery scans onto the live video feed, potentially making it easier to see and remove benign tumors. Forty patients took part, and the main goal was to measure surgeon comfort and feasibility using a standard workload scale.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
augmented reality device
What this could lead to
If successful, this could show that augmented reality makes it easier for surgeons to see and remove benign tumors during minimally invasive gynecologic surgery.
What could go wrong
This is a small, early feasibility study with only 40 patients. It measures surgeon comfort, not patient outcomes, so it may not lead to widespread use or prove that the technology improves health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Mar 2023

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 84 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged between 18 (included) and 84 (included), * Patient with intrauterine myoma, with indication for surgical management by laparoscopic myomectomy, or uterine pathology with indication for surgical management by laparoscopic hysterectomy, * Patient affiliated or beneficiary of a health insurance scheme, * Patient agreeing to participate in the study after having received the written information document and signed the consent form. Exclusion Criteria: * Patients under 18 or over 84 years of age, * Patients with contraindications to MRI (pacemaker, ocular metal splinters, etc.), * Impossibility of planned surgery, * Patient with endometrial cancer contraindicating laparoscopic surgery, * Known pregnant or breast-feeding patient, * Patient of legal age, under guardianship or curatorship, * Patients whose regular follow-up is impossible for geographical, psychological, family or social reasons (these reasons will be collected).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenomyoma of uterus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adenomyoma of uterine corpus adenomyosis myofibroma uterine corpus leiomyoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adenomyoma of uterus Myoma;uterus

Contacts and locations

Locations

  • CHU Clermont-Ferrand

    Clermont-Ferrand, France

  • CHU de Saint-Étienne

    Saint-Etienne, France

  • Polyclinique Urbain V

    Avignon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.